753 related articles for article (PubMed ID: 17824581)
21. Benzoyl peroxide: a review of its current use in the treatment of acne vulgaris.
Sagransky M; Yentzer BA; Feldman SR
Expert Opin Pharmacother; 2009 Oct; 10(15):2555-62. PubMed ID: 19761357
[TBL] [Abstract][Full Text] [Related]
22. Benzoyl peroxide microsphere cream as monotherapy and combination treatment of acne.
Bikowski J; Del Rosso JQ
J Drugs Dermatol; 2008 Jun; 7(6):590-5. PubMed ID: 18561594
[TBL] [Abstract][Full Text] [Related]
23. Treatment of moderate to severe acne vulgaris in a Hispanic population: a post-hoc analysis of efficacy and tolerability of clindamycin phosphate 1.2%/benzoyl peroxide 2.5% gel.
Cook-Bolden FE
J Drugs Dermatol; 2012 Apr; 11(4):455-9. PubMed ID: 22453581
[TBL] [Abstract][Full Text] [Related]
24. The efficacy, safety, and tolerability of adapalene versus benzoyl peroxide in the treatment of mild acne vulgaris: a randomized trial.
Babaeinejad SH; Fouladi RF
J Drugs Dermatol; 2013 Jul; 12(7):790-4. PubMed ID: 23884492
[TBL] [Abstract][Full Text] [Related]
25. A randomized, investigator-blinded trial to assess the antimicrobial efficacy of a benzoyl peroxide 5%/ clindamycin phosphate 1% gel compared with a clindamycin phosphate 1.2%/tretinoin 0.025% gel in the topical treatment of acne vulgaris.
Jackson JM; Fu JJ; Almekinder JL
J Drugs Dermatol; 2010 Feb; 9(2):131-6. PubMed ID: 20214175
[TBL] [Abstract][Full Text] [Related]
26. [Treating acne: avoid the development of antibiotic resistance by applying topical and combined therapy].
Abeck D
MMW Fortschr Med; 2003 Dec; 145(51-52):29. PubMed ID: 14974325
[No Abstract] [Full Text] [Related]
27. Study of the efficacy, tolerability, and safety of 2 fixed-dose combination gels in the management of acne vulgaris.
Zouboulis CC; Fischer TC; Wohlrab J; Barnard J; AliĆ³ AB
Cutis; 2009 Oct; 84(4):223-9. PubMed ID: 19911678
[TBL] [Abstract][Full Text] [Related]
28. Solubilized benzoyl peroxide versus benzoyl peroxide/clindamycin in the treatment of moderate acne.
Tanghetti E; Kircik L; Wilson D; Dhawan S
J Drugs Dermatol; 2008 Jun; 7(6):534-8. PubMed ID: 18561583
[TBL] [Abstract][Full Text] [Related]
29. Clindamycin phosphate 1.2%/benzoyl peroxide 3% fixed-dose combination gel versus topical combination therapy of adapalene 0.1% gel and clindamycin phosphate 1.2% gel in the treatment of acne vulgaris in Japanese patients: A multicenter, randomized, investigator-blind, parallel-group study.
Hayashi N; Kurokawa I; Siakpere O; Endo A; Hatanaka T; Yamada M; Kawashima M
J Dermatol; 2018 Aug; 45(8):951-962. PubMed ID: 29905384
[TBL] [Abstract][Full Text] [Related]
30. Preadolescent moderate acne vulgaris: a randomized trial of the efficacy and safety of topical adapalene-benzoyl peroxides.
Eichenfield LF; Draelos Z; Lucky AW; Hebert AA; Sugarman J; Stein Gold L; Rudisill D; Liu H; Manna V
J Drugs Dermatol; 2013 Jun; 12(6):611-8. PubMed ID: 23839175
[TBL] [Abstract][Full Text] [Related]
31. Newer approaches in topical combination therapy for acne.
Fu LW; Vender RB
Skin Therapy Lett; 2011 Oct; 16(9):3-6. PubMed ID: 22089505
[TBL] [Abstract][Full Text] [Related]
32. Are 2 combined antimicrobial mechanisms better than 1 for the treatment of acne vulgaris? Clinical and antimicrobial results of a topical combination product containing 1% clindamycin and 5% benzoyl peroxide. Introduction.
Leyden J
Cutis; 2001 Feb; 67(2 Suppl):5-7. PubMed ID: 11236213
[TBL] [Abstract][Full Text] [Related]
33. Adapalene-benzoyl peroxide once-daily, fixed-dose combination gel for the treatment of acne vulgaris: a randomized, bilateral (split-face), dose-assessment study of cutaneous tolerability in healthy participants.
Andres P; Pernin C; Poncet M
Cutis; 2008 Mar; 81(3):278-84. PubMed ID: 18441854
[TBL] [Abstract][Full Text] [Related]
34. A new treatment for acne vulgaris combining benzoyl peroxide with clindamycin.
Tschen E; Jones T
J Drugs Dermatol; 2002 Sep; 1(2):153-7. PubMed ID: 12847739
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of tretinoin 0.025%/clindamycin phosphate 1.2% gel in combination with benzoyl peroxide 6% cleansing cloths for the treatment of facial acne vulgaris.
Zeichner JA; Wong V; Linkner RV; Haddican M
J Drugs Dermatol; 2013 Mar; 12(3):277-82. PubMed ID: 23545909
[TBL] [Abstract][Full Text] [Related]
36. The evolution of benzoyl peroxide therapy.
Tanghetti E
Cutis; 2008 Nov; 82(5 Suppl):5-11. PubMed ID: 19202772
[TBL] [Abstract][Full Text] [Related]
37. Fixed-combination clindamycin 1%-benzoyl peroxide 5% hydrating gel: a flexible component of acne management.
Tanghetti E
Cutis; 2009 Nov; 84(5 Suppl):18-24. PubMed ID: 19999189
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and tolerability of a fixed combination of clindamycin phosphate (1.2%) and low concentration benzoyl peroxide (2.5%) aqueous gel in moderate or severe acne subpopulations.
Webster G; Rich P; Gold MH; Mraz S; Calvarese B; Chen D
J Drugs Dermatol; 2009 Aug; 8(8):736-43. PubMed ID: 19663111
[TBL] [Abstract][Full Text] [Related]
39. Advancement in benzoyl peroxide-based acne treatment: methods to increase both efficacy and tolerability.
Fakhouri T; Yentzer BA; Feldman SR
J Drugs Dermatol; 2009 Jul; 8(7):657-61. PubMed ID: 19588642
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and tolerability of fixed-combination acne treatment in adolescents.
Gold LS
Cutis; 2013 Mar; 91(3):152-9. PubMed ID: 23617089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]